Dare Bioscience Inc.

1.25+0.0300+2.46%Vol 245.94K1Y Perf -20.78%
Aug 5th, 2022 16:00 DELAYED
BID1.25 ASK1.28
Open1.20 Previous Close1.22
Pre-Market- After-Market1.28
 - -  0.03 2.40%
Target Price
4.80 
Analyst Rating
Strong Buy 1.00
Potential %
284.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
20.75 
Earnings Rating
Strong Buy
Market Cap105.89M 
Earnings Date
9th Aug 2022
Alpha-0.01 Standard Deviation0.22
Beta1.39 

Today's Price Range

1.181.27

52W Range

0.92012.51

5 Year PE Ratio Range

-1.30-1.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
12.61%
1 Month
0.81%
3 Months
14.68%
6 Months
-19.87%
1 Year
-20.78%
3 Years
66.67%
5 Years
-59.15%
10 Years
-

TickerPriceChg.Chg.%
DARE1.250.03002.46
AAPL165.35-0.2300-0.14
GOOG118.22-0.6500-0.55
MSFT282.91-0.7400-0.26
XOM88.451.26001.45
WFC43.760.99002.31
JNJ171.11-0.6800-0.40
FB196.640.99000.51
GE74.360.69000.94
JPM115.763.40003.03
 
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.14-0.1028.57
Q04 2021-0.21-0.1814.29
Q03 2021-0.11-0.18-63.64
Q02 2021-0.15-0.18-20.00
Q01 2021-0.23-0.1630.43
Q04 2020-0.20-0.22-10.00
Q03 2020-0.15-0.24-60.00
Q02 2020-0.14-0.27-92.86
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.0466.67Positive
9/2022 QR-0.14-7.69Negative
12/2022 FY-0.3625.00Positive
12/2023 FY-0.36-50.00Negative
Next Report Date9th Aug 2022
Estimated EPS Next Report-0.04
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume245.94K
Shares Outstanding84.71K
Shares Float68.86M
Trades Count1.34K
Dollar Volume303.10K
Avg. Volume612.38K
Avg. Weekly Volume390.43K
Avg. Monthly Volume517.46K
Avg. Quarterly Volume929.25K

Dare Bioscience Inc. (NASDAQ: DARE) stock closed at 1.25 per share at the end of the most recent trading day (a 2.46% change compared to the prior day closing price) with a volume of 245.94K shares and market capitalization of 105.89M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 18 people. Dare Bioscience Inc. CEO is Sabrina Martucci Johnson.

The one-year performance of Dare Bioscience Inc. stock is -20.78%, while year-to-date (YTD) performance is -37.5%. DARE stock has a five-year performance of -59.15%. Its 52-week range is between 0.9201 and 2.51, which gives DARE stock a 52-week price range ratio of 20.75%

Dare Bioscience Inc. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 3.37, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -134.55%, a ROC of -221.31% and a ROE of -234.25%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Dare Bioscience Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.04 for the next earnings report. Dare Bioscience Inc.’s next earnings report date is 09th Aug 2022.

The consensus rating of Wall Street analysts for Dare Bioscience Inc. is Strong Buy (1), with a target price of $4.8, which is +284.00% compared to the current price. The earnings rating for Dare Bioscience Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dare Bioscience Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dare Bioscience Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.78, ATR14 : 0.08, CCI20 : 82.10, Chaikin Money Flow : -0.17, MACD : -0.01, Money Flow Index : 54.52, ROC : 5.04, RSI : 38.83, STOCH (14,3) : 90.91, STOCH RSI : 1.00, UO : 58.35, Williams %R : -9.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dare Bioscience Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Dare Bioscience Inc.

Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women's reproductive health. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.

CEO: Sabrina Martucci Johnson

Telephone: +1 858 926-7655

Address: 3655 Nobel Drive, San Diego 92122, CA, US

Number of employees: 18

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

64%36%

Bearish Bullish

64%36%


News

Stocktwits